September 26, 2016 1:48 AM ET

Healthcare Equipment and Supplies

Company Overview of Singulex, Inc.

Company Overview

Singulex, Inc. develops and provides single molecule counting (SMC) technology for clinical diagnostics and scientific discovery. The company offers Sgx Clarity System, an immunodiagnostic platform that is designed to detect low abundance biomarkers at levels down to femtograms/mL. Its system provides proactive cardiovascular health management for clinicians; heart disease and wellness monitoring services for patients; and personalized wellness programs and clinical health education to patients and physicians. It also provides ultra-sensitive immunoassay solutions and laboratory testing services that help patient care from reactive disease treatment to proactive health management and fueling...

1701 Harbor Bay Parkway

Suite 200

Alameda, CA 94502

United States

Founded in 1997

177 Employees

Phone:

510-995-9000

Fax:

510-995-9092

Key Executives for Singulex, Inc.

Chief Executive Officer, President and Director
Age: 51
Chief Financial Officer
Senior Vice President of Operations
Vice President of Human Resources
Compensation as of Fiscal Year 2016.

Singulex, Inc. Key Developments

Singulex Enters into World-Wide Service Agreement with Tecan

Singulex, Inc. announced the conclusion of a world-wide service agreement with Tecan Group to deliver comprehensive maintenance and support for its Sgx Clarity(TM) System. The Sgx Clarity System, currently in development and not yet approved for sale, is a fully automated, Next Generation Immunodiagnostics platform designed to bring the benefits of Singulex's SMC technology to hospital and reference labs worldwide. It is designed to overcome the existing sensitivity barriers in immunochemistry diagnostics. Through the agreement, Tecan will deliver comprehensively scheduled maintenance and technical support. Once the Sgx Clarity System is approved for sale, hospital and reference labs will have access to next generation immunodiagnostics with sensitivity targets that are more than 100-times greater than currently available devices and the confidence of expert maintenance and support across the globe.

Grifols Signs Licensing Agreement with Singulex

Grifols, S.A. has entered into a worldwide license agreement with Singulex, Inc. for the use and commercialization of Singulex's technology for screening plasma and blood donation that allows garnatizar further the safety of transfusions and plasma products.

Singulex, Inc. Presents at JPMorgan 34th Annual Healthcare Conference, Jan-14-2016 10:00 AM

Singulex, Inc. Presents at JPMorgan 34th Annual Healthcare Conference, Jan-14-2016 10:00 AM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, California, United States. Speakers: Guido Baechler, Chief Executive Officer, President and Director.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
May 17, 2016
--
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Singulex, Inc., please visit www.singulex.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.